These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7847670)

  • 41. Immunological aspects of motor neuron disease.
    Shy ME
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():241-56. PubMed ID: 2183314
    [No Abstract]   [Full Text] [Related]  

  • 42. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement.
    Pullen AH; Demestre M; Howard RS; Orrell RW
    Acta Neuropathol; 2004 Jan; 107(1):35-46. PubMed ID: 14551798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Internal neurology--b. Degenerative nerve diseases--approach to etiology].
    Kanazawa I
    Nihon Rinsho; 1987 Sep; 45(9):2133-43. PubMed ID: 2828719
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Vincent A; Newsom-Davis J
    Lancet; 1989 Nov; 2(8671):1107. PubMed ID: 2572837
    [No Abstract]   [Full Text] [Related]  

  • 45. Experimental autoimmune motoneuron disease.
    Engelhardt JI; Appel SH; Killian JM
    Ann Neurol; 1989 Sep; 26(3):368-76. PubMed ID: 2802536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle.
    Delbono O; García J; Appel SH; Stefani E
    Am J Physiol; 1991 Jun; 260(6 Pt 1):C1347-51. PubMed ID: 1647668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
    Fairless R; Williams SK; Diem R
    Cell Tissue Res; 2014 Aug; 357(2):455-62. PubMed ID: 24326615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voltage-dependent Ca2+ channels in small cell carcinomas are blocked by autoantibodies from patients with Lambert-Eaton myasthenic syndrome.
    De Aizpurua HJ; Griesmann GE; Lambert EH; Lennon VA
    Ann N Y Acad Sci; 1988; 540():369-71. PubMed ID: 2849894
    [No Abstract]   [Full Text] [Related]  

  • 49. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
    Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
    Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
    [No Abstract]   [Full Text] [Related]  

  • 52. Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature.
    Mehanna R; Patton EL; Phan CL; Harati Y
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):82-5. PubMed ID: 23172389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Calcium ion is a common denominator in the pathophysiological processes of amyotrophic lateral sclerosis].
    Patai R; Nógrádi B; Meszlényi V; Obál I; Engelhardt J; Siklós L
    Ideggyogy Sz; 2017 Jul; 70(7-8):247-257. PubMed ID: 29870639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.
    Goldstein JM; Waxman SG; Vollmer TL; Lang B; Johnston I; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1138-9. PubMed ID: 8089692
    [No Abstract]   [Full Text] [Related]  

  • 55. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis.
    Appel SH; Smith RG; Alexianu M; Siklos L; Engelhardt J; Colom LV; Stefani E
    Clin Neurosci; 1995-1996; 3(6):368-74. PubMed ID: 9021258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunology of amyotrophic lateral sclerosis.
    Antel JP; Noronha AB; Oger JJ; Arnason BG
    Adv Neurol; 1982; 36():395-402. PubMed ID: 6817615
    [No Abstract]   [Full Text] [Related]  

  • 57. Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases.
    Barker R
    Rev Neurosci; 1996; 7(3):187-214. PubMed ID: 8916292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis.
    Maglemose R; Hedegaard A; Lehnhoff J; Dimintiyanova KP; Moldovan M; Grøndahl L; Meehan CF
    Exp Neurol; 2017 Jun; 292():154-167. PubMed ID: 28322742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome. Morphologic evidence for depletion and that the depletion is mediated by autoantibodies.
    Engel AG; Nagel A; Fukuoka T; Fukunaga H; Osame M; Lang B; Newsom-Davis J; Vincent A; Wray DW; Peers C
    Ann N Y Acad Sci; 1989; 560():278-90. PubMed ID: 2545141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.